Paola Leone | Neuronal Cell Biology | Pioneer Researcher Award

Prof. Dr. Paola Leone | Neuronal Cell Biology | Pioneer Researcher Award

Rowan-Virtua SOM and Virtua Health College of Medicine and Life Sciences of Rowan University | United States

Dr. Paola Leone is a neuroscientist and cell biologist whose work focuses on pediatric white matter diseases, mechanisms of myelination, and gene/cell‐based therapies to repair white matter pathology. After completing a doctoral degree in Neuroscience at the University of Padua (Italy), she undertook a post‑doctoral fellowship in Behavioral Neurobiology at Concordia University, Montreal, where early work included studies on dopamine receptors and opioid interaction in reward pathways. Over subsequent decades, her research has expanded to include using viral vector models, evaluating gene expression in glial and neuronal interactions, and metabolic demands in neurological disease models such as Alzheimer’s and leukodystrophies. According to institutional metrics, her department (Cell Biology at Rowan University) shows ~6,735 citations and an h‑index of 44 across roughly 176 articles (plus reviews and other contributions). Roan University These figures reflect both leadership in publications and influence in the neuroscience/cell biology community. Her scholarly contributions have significantly advanced understanding of neuron‑glia energetics, genetic regulation of myelination, and translational strategies for repair in white matter disease.

Profile: Scopus

Featured Publications:

  • “Blockade of D1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning”

  • “5HT3 receptor antagonists block morphine and nicotine- but not amphetamine-induced reward”

  • “SCH 23390 blocks drug-conditioned place preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?”

  • “Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release as measured by in vivo microdialysis”

  • “Intrahippocampal injection of a HSV-1 vector expressing GluR6 induces spontaneous limbic seizures and CA1 and CA3 hyperexcitability”

  • “Differential involvement of ventral tegmental Mu, Delta and Kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies”

  • “Ventral mesencephalic & opioid are involved in modulation of basal mesolimbic dopamine neurotransmission: an anatomical localization study”

  • “Striatal tissue preparation facilitates early sampling in microdialysis and reveals an index of neuronal damage”

  • “Mesolimbic dopamine neurotransmission is increased by administration of µ-opioid receptor antagonists”

  • “Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures”

Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Prof. Dr. Rizwan Khan | Diabetic Neuropathy | Best Researcher Award

Aligarh Muslim University | India

Dr. Rizwan Hasan Khan is a distinguished professor at the Interdisciplinary Biotechnology Unit of Aligarh Muslim University, specializing in biophysical chemistry and molecular interactions related to protein aggregation and therapeutic drug design. With a Ph.D. awarded focused on lectins, Dr. Khan has significantly contributed to understanding protein fibrillation, aggregation mechanisms, and their inhibition, particularly in relation to amyloid diseases and antimicrobial resistance. His research encompasses the biophysical characterization of proteins, the impact of toxins and drugs on protein behavior, and the identification of novel inhibitors through computational and experimental approaches. Dr. Khan’s prolific output includes over 16 peer-reviewed research and review articles published in reputed journals such as Biophysical Chemistry, Archives of Biochemistry and Biophysics, and Cell Reports, reflecting interdisciplinary expertise in biotechnology, biochemistry, and drug discovery. His work has attracted citations highlighting its influence in the fields of amyloid research and therapeutic development. Dr. Khan maintains an h-index indicative of sustained scholarly impact, underscoring his role as a leading researcher in molecular biophysics and pharmacology. His research continues to advance knowledge in combating protein aggregation disorders and antimicrobial resistance, contributing valuable insights into novel drug candidates and molecular mechanisms.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu (II) flufenamate chemotherapeutic drug candidate”

  • “Ponceau 4R induces aggregation in human serum albumin and morin acts as an anti-aggregating agent against dye induced aggregates”

  • “Hippuric acid, a uremic toxin, binds to aggregation prone region of human lysozyme and potentiates the fibrillation: A biophysical insight”

  • “Identification of potential inhibitors of Ubiquitin carboxyl-terminal hydrolase 21 from repurposed drugs: Implications in anticancer therapeutics”

  • “Loss of Neurofibromin Induces Inflammatory Macrophage Phenotypic Switch and Retinal Neovascularization via GLUT1 Activation”

  • “Employing spectroscopic, calorimetric and structural bioinformatics approaches to decipher the binding mechanism of mangiferin with human transferrin”

  • “Interaction of Esculetin with Alpha-2-Macroglobulin: Biochemical and Biophysical Approaches”

  • “Utilizing non-β-lactam antibiotics to combat antimicrobial resistance by targeting multiple virulence factors of Pseudomonas aeruginosa”

  • “Strategies for inhibiting amyloid fibrillation: Current status and future prospects”

  • “Assessing the role of Berberine as an inhibitor of advanced glycation end products (AGEs) formation using in vitro and molecular interaction studies”

Bao-Min Yao | Microbial Cell Biology | Best Researcher Award

Mr. Bao-Min Yao | Microbial Cell Biology | Best Researcher Award

Research Center for Eco-Environmental Sciences | China

Bao-Min Yao is a distinguished researcher affiliated with multiple prestigious institutions, including the School of Environmental & Resource Sciences at Shanxi University, the State Key Laboratory of Urban and Regional Ecology at the Research Center for Eco-Environmental Sciences of the Chinese Academy of Sciences, the University of Chinese Academy of Sciences, the School of Life Sciences at Hebei University, and the Municipal Engineering Department at Beijing University of Technology. His interdisciplinary work spans environmental science, urban ecology, and civil engineering, reflecting a comprehensive approach to addressing complex ecological and environmental challenges. Over the course of his career, Bao-Min Yao has authored a substantial number of scientific publications, contributing significantly to the advancement of knowledge in his fields of expertise. His research output has been widely recognized, as evidenced by a strong citation record and a notable h-index, indicating both the productivity and the impact of his work within the scientific community. His contributions encompass studies on ecological sustainability, resource management, and environmental protection, underpinning policy and technological innovation. Bao-Min Yao’s dedication to research excellence is further demonstrated through his collaborative engagements across institutions, fostering interdisciplinary dialogues and innovations. His scholarly influence is reflected in the volume of citations his work has garnered, underscoring his role as a leading voice in environmental and ecological research.

Profile: Scopus

Featured Publications:

“Soil pH and bacterial diversity synergistically regulate trace element transfer and accumulation in soil-rice systems”

Maria Antonietta Grignano | Cellular Stress Response | Best Researcher Award

Dr. Maria Antonietta Grignano | Cellular Stress Response | Best Researcher Award

Fondazione IRCCS Policlinico San Matteo di Pavia | Italy

Dr. Maria Antonietta Grignano is a biologist and specialist in clinical pathology and biochemistry, currently serving as a researcher and head of the Research Laboratory of the Nephrology, Dialysis, and Transplantation Unit at Fondazione IRCCS Policlinico San Matteo. Her research has focused on innovative strategies in kidney transplantation, ischemia-reperfusion injury, and the use of mesenchymal stromal cell-derived extracellular vesicles for organ conditioning. She has contributed to both preclinical and translational studies, with a particular emphasis on engineered vesicles and molecular profiling in transplant immunology. Dr. Grignano has authored over 30 scientific publications indexed in Scopus and Web of Science, contributing to high-impact journals such as the International Journal of Molecular Sciences, Blood Purification, and Transplant International. Her work includes collaborations with national institutions like the University of Pavia and international partners including Columbia University and universities in the Netherlands. As a recognized reviewer for several peer-reviewed journals, she maintains a strong presence in academic publishing. According to Scopus, she has an h-index of 8 with 162 total citations, and 9 citations indexed in Web of Science, reflecting the growing recognition of her work in nephrology and transplant science. Her scientific contributions span experimental design, data analysis, and dissemination of findings.

Profiles: Scopus | Orcid

Featured Publications:

  • “A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model”

  • “Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model”

  • “Pre-transplant IE1-specific T-cell response and CD8 + T-cell count as predictive markers of treated HCMV reactivation in kidney transplant recipients”

  • “Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review”

  • “The Impact of Serum/Plasma Proteomics on SARS-CoV-2 Diagnosis and Prognosis”

  • “Sputum proteomics in lung disorders”

  • “Induction of Vesicular Trafficking and JNK-Mediated Apoptotic Signaling in Mononuclear Leukocytes Marks the Immuno-Proteostasis Response to Uremic Proteins”

  • “CD73-Adenosinergic Axis Mediates the Protective Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Ischemic Renal Damage in a Rat Model of Donation after Circulatory Death”

  • “SARS-CoV-2-specific IgG and NCP in vulnerable patients without symptoms”

  • “Liposome Formulation and In Vitro Testing in Non-Physiological Conditions Addressed to Ex Vivo Kidney Perfusion”

 

 

Ali Alahmari | Stem Cell Transplantation | Best Researcher Award

Dr. Ali Alahmari | Stem Cell Transplantation | Best Researcher Award

Kfshrc | Saudi Arabia

Dr. Ali Alahmari is a distinguished consultant in Acute Leukemia, Hematology, Hematopoietic Stem Cell Transplantation (HSCT), and Cellular Therapy at King Faisal Specialist Hospital & Research Centre. He earned his MBBS degree from King Saud University and completed his internship at King Khalid University Hospital. He has held a key consultant position, contributing extensively to the advancement of cellular therapy and bone marrow transplantation in Saudi Arabia. Dr. Alahmari has made significant academic contributions to the field, particularly in hemato-hepatology and sickle cell disease. His research has focused on novel transplant approaches, including haploidentical stem cell transplantation after liver transplantation and donor impact in severe aplastic anemia. He has co-authored over 22 scientific documents, with his work accumulating more than 629 citations and earning an h-index of 12, reflecting the depth and influence of his research. His notable publications include titles such as Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia and Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction.” Dr. Alahmari’s ongoing efforts continue to shape clinical best practices and research frameworks for hematologic disorders and transplantation medicine in the region.

Profile: Scopus

Featured Publications:

  • “Author Correction: Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series”

  • “Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT”

  • “Emerging need for a hepato-hematology program for patients with sickle cell disease in Saudi Arabia”

  • “Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series”

  • “Hematopoietic Stem Cell Transplantation in Sickle Cell Disease”

  • “Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation”

  • “Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience”

Nofel Binicier | Cellular Mechanotransduction Pathways | Best Researcher Award

Dr. Nofel Binicier | Cellular Mechanotransduction Pathways | Best Researcher Award

University of Health Sciences, Bursa City Hospital, Department of Cardiovasculary Surgery, Bursa | Turkey

Dr. Nöfel Ahmet Binicier is a vascular and adult cardiac surgeon affiliated with the Department of Cardiovascular Surgery at a major university hospital  following six years of service in multiple hospitals across Turkey. He holds an MD from Uludağ University, having specialized in cardiovascular and vascular surgery. His clinical and research interests encompass vascular surgery, adult cardiac surgery, endovascular interventions, and management of complex cardiovascular disease, including techniques for open and endovascular repair of arterial and venous disease, valve repair and replacement, coronary artery bypass grafting, and surgery for aortic aneurysm and dissection, along with perioperative patient management. He has contributed to several peer‑reviewed articles on rare and challenging cardiovascular cases, including atrial myxoma mimicking bronchial asthma; left main coronary stent protrusion requiring surgical removal; reoperations in multivalvular dysfunction; chronic type II aortic dissection with pericardial tamponade; and caseous calcification of the mitral annulus. His work has amassed approximately [documents_count] published documents, [citations_count] total citations, and an h‑index of [h_index], reflecting his academic productivity and impact in the field. He is a professional member of national and European societies of cardiovascular and vascular surgery, and is fluent in Turkish and English.

Profile: Oricd

Featured Publications:

  • “En bloc resection of a left atrial myxoma mimicking bronchial asthma: a case report”

  • “Aortic protrusion of left main coronary artery stent during percutaneous coronary intervention after redo mitral valve replacement: surgical removal and new stent implantation”

  • “Reoperation for acquired discrete subaortic membrane and multivalvular dysfunction after mitral valve replacement”

  • “A rare case of chronic type II DeBakey aortic dissection complicated by chronic massive pericardial effusion and cardiac tamponade”

  • “A rare complication of percutaneous pulmonary valve implantation, successful implantation of the valve stripped from the delivery system by emergency open surgery, and restored to the delivery system”

  • “Surgical treatment of caseous calcification of the mitral annulus causing mitral stenosis and mimicking the clinical picture of infective endocarditis: A case report”

Alexander Tsankov | Cancer Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Alexander Tsankov | Cancer Cell Biology | Best Researcher Award

Icahn School Of Medicine At Mount Sinai | United States

Alexander Tsankov is a leading researcher in computational biology and cancer genomics, known for his contributions to single-cell and spatial transcriptomics. He holds dual bachelor’s degrees in Plan II Honors and Electrical and Computer Engineering from the University of Texas at Austin, and earned his M.S. and Ph.D. in Electrical Engineering and Computer Science from MIT. His research focuses on understanding the cellular and molecular mechanisms underlying cancer progression and tissue remodeling, with an emphasis on glioblastoma, lung adenocarcinoma, and colorectal cancer. Dr. Tsankov has published extensively in top-tier journals such as Nature, Nature Communications, Cancer Discovery, Nature Genetics, and Immunity. He has authored over 50 peer-reviewed publications, with an h-index of 36 and more than 15,000 citations according to Google Scholar. His work has earned him several prestigious honors, including the NIH NRSA postdoctoral fellowship and the NSF graduate fellowship. Dr. Tsankov frequently serves as a senior or corresponding author, highlighting his leadership in the field of computational oncology and single-cell genomics.

Profile: Google Scholar

Featured Publications:

  • “Learning the cellular origins across cancers using single-cell chromatin landscapes”

  • “Cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma”

  • “Single cell profiling of human airway identifies tuft-ionocyte progenitor cells displaying cytokine-dependent differentiation bias in vitro”

  • “Single-cell dissection of the genotype-immunophenotype relationship in glioblastoma”

  • “Glioblastoma shift from bulk to infiltrative growth is guided by plexin-B2-mediated microglia alignment in invasive niches”

  • “Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer”

  • “NOTCH1 drives sexually dimorphic immune responses in hepatocellular carcinoma”

  • “Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations”

  • “Single cell view of tumor microenvironment gradients in pleural mesothelioma”

  • “Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines”

Vicentiu Radulescu | Cell Differentiation Processes | Best Researcher Award

Prof. Dr. Vicentiu Radulescu | Cell Differentiation Processes | Best Researcher Award

AGH University of Krakow | Poland

Vicenţiu D. Rădulescu is a Romanian mathematician whose research spans nonlinear analysis, variational methods, and partial differential equations, particularly those involving singularities, variable exponents, and nonlocal features. He obtained his Ph.D. from Université Pierre et Marie Curie (Paris VI) under Haim Brezis, affiliated with the highest distinction; he later completed his habilitations both there (2003) and at AGH University of Science and Technology, Kraków. He currently holds full professorship at the University of Craiova, and research professorships in Poland and Czech Republic, as well as a fellowship at the Romanian Academy. According to open‐source metrics, he has published about 619 documents, with over 15,200 citations and an h‑index of 60. His work includes several books and many papers in leading journals, and he has received multiple recognitions such as being listed among the world’s top 2 % of scientists and several “Highly Cited Researcher” distinctions.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

  • “Variational methods for nonlocal fractional problems”

  • “Partial differential equations with variable exponents: variational methods and qualitative analysis”

  • “Nonlinear analysis-theory and methods”

  • “Singular elliptic problems: bifurcation and asymptotic analysis”

  • “A multiplicity result for a nonlinear degenerate problem arising in the theory of electrorheological fluids”

  • “On a nonhomogeneous quasilinear eigenvalue problem in Sobolev spaces with variable exponent”

  • “Nonlinear elliptic equations with variable exponent: old and new”

  • “Variational principles in mathematical physics, geometry, and economics: Qualitative analysis of nonlinear equations and unilateral problems”

  • “Recent developments in problems with nonstandard growth and nonuniform ellipticity”

  • “Eigenvalue problems for anisotropic quasilinear elliptic equations with variable exponent”

Devendra Jain | Nano-Biotechnology | Best Researcher Award

Dr. Devendra Jain | Nano-Biotechnology | Best Researcher Award

MPUAT | India

Dr. Devendra Jain is an accomplished Assistant Professor in the Department of Molecular Biology and Biotechnology at Rajasthan College of Agriculture, Maharana Pratap University of Agriculture and Technology, Udaipur, India. With a strong academic foundation, including a Ph.D. in Science from Rajasthan University and an M.Sc. in Plant Biotechnology from Tamil Nadu Agricultural University, he has made significant contributions to agricultural microbiology and plant biotechnology. His research interests focus on plant-microbe interactions, bioremediation, nanobiotechnology, and the development of microbial inoculants for sustainable agriculture. Dr. Jain has published over 100 Scopus-indexed, peer-reviewed research papers in reputed international journals, reflecting the depth and breadth of his scientific expertise. His work has received widespread recognition, accumulating more than 1,200 citations, with an h-index of 19, highlighting both the quality and impact of his research. Notably, his studies on zinc-solubilizing and plant growth-promoting bacteria, as well as the application of nanotechnology in agriculture, have contributed significantly to soil health and crop productivity under abiotic stress conditions. Through interdisciplinary collaborations and applied research, Dr. Jain continues to advance knowledge in agricultural biotechnology, positioning himself as a key contributor to India’s sustainable farming research landscape.

Profiles: Scopus | Orcid

Featured Publications:

  • “Optimization and characterization of an extracellular proteases from aspergillus flavus ‘MTCC 277′”

  • “Screening and Optimization of Zinc Removal Potential in Pseudomonas aeruginosa-HMR1 and its Plant Growth-Promoting Attributes”

  • “Heterosis Studies for Root-Yield-Attributing Characters and Total Alkaloid Content over Different Environments in Withania somnifera L.”

  • “Efficacy evaluation of newly isolated zinc solubilizing bacteria for their potential effect on maize (Zea mays L.) under zinc deficient soil conditions”

  • “Assessment of genetic and biochemical diversity of ecologically variant ectomycorrhizal Russula sp. from India”

  • “Molecular Diversity Analysis of Plant Growth Promoting Rhizobium Isolated from Groundnut and Evaluation of Their Field Efficacy”

  • “SSR-marker assisted evaluation of genetic diversity in mungbean (Vigna radiata (L.) Wilcezk) genotypes”

  • “Isolation and assessment of genetic diversity of plant growth promoting and abiotic stress tolerant chickpea mesorhizobia”

Qi Gao | 3D Co-Culture | Best Researcher Award

Dr. Qi Gao | 3D Co-Culture | Best Researcher Award

Dr. Qi Gao | Stanford University | United States

Dr. Qi Gao is a dedicated biomedical scientist with over a decade of research experience in molecular biology, regenerative medicine, and tissue engineering. With a Ph.D. in Biomedical Engineering from the City University of Hong Kong, Dr. Gao currently conducts translational research at Stanford University. Her work explores the intricate cellular interactions in 3D tissue models, focusing on macrophage and mesenchymal stromal cell dynamics under inflammatory and oxidative stress conditions. Dr. Gao is recognized for her interdisciplinary approach, blending biology, engineering, and advanced analytics to solve clinical challenges in orthopaedics and joint degeneration. She has co-authored numerous high-impact publications and has mentored young scientists in experimental methods and protein misfolding mechanisms. Her work is frequently published in top-tier journals and presented at international conferences. With strong teaching, communication, and analytical skills, Dr. Gao is a prominent contributor to innovations in personalized medicine and regenerative healthcare solutions.

Publication Profile: 

Orcid

Education:

Dr. Qi Gao earned her Ph.D. in Biomedical Engineering from the City University of Hong Kong , where she built a strong foundation in cellular biology, protein misfolding, and regenerative tissue modeling. During her doctoral studies, she actively contributed to teaching undergraduate students in the Biosafety in Equipment and Facilities course, conducting eighteen classes per seminar. She also served as a mentor to seven undergraduate students, advising their theses in protein misfolding and providing hands-on experimental guidance twice weekly. Her academic training reflects a rigorous, research-intensive environment combined with mentorship and teaching responsibilities. This background has given her deep expertise in experimental design, data synthesis, and translational applications of biomedical innovations. Since completing her Ph.D., she has pursued postdoctoral and collaborative research opportunities at Stanford University, further expanding her skills in regenerative medicine, AI-assisted imaging, and macrophage-mediated joint modeling for translational use in orthopaedics.

Experience:

Dr. Qi Gao brings 10+ years of research and academic experience across global institutions. At the City University of Hong Kong, she conducted pioneering research into protein misfolding and stem cell biology. She transitioned to Stanford University, where she has been a driving force behind multiple 3D tissue engineering and inflammation modeling projects. Her work at Stanford includes the development of innervated organoids, macrophage-stem cell interaction models, and AI applications in orthopaedic imaging. Qi has mentored students, collaborated with leading scientists, and managed complex translational research projects. She possesses strong technical skills in cell culture, biomaterials, confocal microscopy, flow cytometry, and molecular analysis. Beyond bench science, she is proficient in scientific writing, grant applications, and interdisciplinary collaboration. Her research addresses real-world clinical problems such as osteoarthritis, bone degeneration, and inflammation, positioning her as a key contributor in advancing regenerative medicine and clinical translation.

Awards and Honors:

Dr. Qi Gao is a two-time recipient of the Translational Research and Applied Medicine (TRAM) Pilot Grant at Stanford University for the cycles, recognizing her innovative approaches to disease modeling and regenerative therapies. These competitive grants fund projects with strong potential for clinical translation and societal impact. Her recognition in academic circles extends beyond funding; she has been selected as a lead author and collaborator in numerous peer-reviewed publications, including journals like Osteoarthritis and Cartilage, Journal of Inflammation Research, and Stem Cell Research & Therapy. She has presented at major scientific conferences and is frequently cited for her work on macrophage modulation, oxidative stress, and joint inflammation models. These accolades demonstrate her commitment to high-impact, interdisciplinary biomedical research and her ability to consistently deliver results that advance both science and clinical care.

Research Focus:

Dr. Qi Gao’s research centers on the cellular and molecular mechanisms underlying joint inflammation, bone regeneration, and tissue remodeling. She specializes in 3D organoid cultures, particularly models that replicate the synovium-cartilage interface and the bone microenvironment. A core theme of her work is understanding how macrophage phenotypes and mesenchymal stromal cells (MSCs) interact to regulate angiogenesis, osteogenesis, and fibrosis, particularly in inflammatory and corticosteroid-impaired settings. She also investigates the use of metformin and other small molecules to mitigate oxidative stress in stem cell therapies. In addition, Dr. Gao is involved in AI-assisted imaging to improve diagnostic accuracy for bone pathologies such as osteonecrosis of the femoral head. Her translational approach bridges basic science with clinical application, enabling her work to influence therapies for osteoarthritis, bone healing, and personalized regenerative medicine. Her future goals include developing biomimetic models that accurately predict treatment responses in orthopaedic diseases.

Publications Top Notes: 

  1. Macrophage phenotypes modulate neoangiogenesis and fibroblast profiles in synovial-like organoid cultures.

  2. An innervated synovium-cartilage chip for modeling knee joint inflammation and associated pain.

  3. Metformin modulates cell oxidative stress to mitigate corticosteroid-induced suppression of osteogenesis in a 3D model.

  4. 3D culture of MSCs for clinical application.

  5. The advantages and shortcomings of stem cell therapy for enhanced bone healing.

  6. Metabolic profile of mesenchymal stromal cells and macrophages in the presence of polyethylene particles in a 3D model.

  7. Macrophages modulate the function of MSC- and iPSC-derived fibroblasts in the presence of polyethylene particles.

  8. The effects of macrophage phenotype on osteogenic differentiation of MSCs in the presence of polyethylene particles.

  9. Optimization of cytometry by time-of-flight staining for peripheral blood and bone marrow samples.

  10. Metformin modulates oxidative stress in murine mesenchymal stem cells and alleviates corticosteroid-induced inflammation.

Conclusion:

Dr. Qi Gao represents an exceptional biomedical researcher whose contributions have directly advanced the fields of tissue engineering, regenerative medicine, and cell therapy. Her body of work demonstrates scientific rigor, innovation, and real-world relevance. With continued leadership in translational research, mentorship of junior scientists, and active collaboration across disciplines, Dr. Gao is not only suitable but highly competitive for the Best Researcher Award. Her scientific career trajectory strongly aligns with the values of the award—excellence, innovation, and societal impact in science.